Santa Ana, CA, United States of America

Carl Cotman

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Cotman. Retrieved from https://idiyas.com/inventor/carl-cotman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Carl Cotman

Introduction

Carl Cotman is a notable inventor based in Santa Ana, CA (US). He has made significant contributions to the field of cognitive function enhancement and anxiety treatment. His work focuses on the modulation of H3K9me3, which has implications for aging and age-related disorders.

Latest Patents

Carl Cotman holds a patent titled "Use of H3K9me3 modulation for enhancing cognitive function." This patent presents a composition that is administered to subjects, comprising a therapeutically effective amount of a SUV39H1 inhibitor, including analogs of ETP69. The invention aims to treat cognitive dysfunction associated with aging and related disorders.

Career Highlights

Throughout his career, Cotman has dedicated himself to research that bridges the gap between neuroscience and therapeutic applications. His innovative approaches have garnered attention in the scientific community, particularly in the context of cognitive health.

Collaborations

Carl Cotman has collaborated with esteemed colleagues, including Larry Overman and Shikha Snigdha. These partnerships have enriched his research and contributed to the advancement of knowledge in his field.

Conclusion

Carl Cotman's work exemplifies the intersection of innovation and practical application in the realm of cognitive health. His contributions continue to influence the development of therapies aimed at enhancing cognitive function and treating anxiety-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…